Is Holmium Laser Enucleation of Prostate equally effective in management of benign prostatic hyperplasia patients with either voiding or storage lower urinary tract symptoms? A comparative study
https://doi.org/10.4081/aiua.2022.2.174
Accepted: May 14, 2022
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Objective: To evaluate and compare the effectiveness and safety of holmium laser enucleation of prostate (HoLEP) in relieving either voiding or storage lower urinary tract symptoms (LUTS) in benign prostatic hyperplasia (BPH) patients. Materials and methods: The charts of patients with BPH who underwent HoLEP for either predominant voiding or predominant storage LUTS at University of Cincinnati hospitals in the period between February 2015 and December 2020 were retrospectively reviewed and analyzed for changes in voiding symptomatology, storage symptomatology, hematuria, International Prostate Symptom Score (IPSS), peak flow rates (Qmax), presence of detrusor overactivity (DO), and post-voiding residual urine (PVR) from baseline to up to 6 months postoperatively. Results: A total of 132 patients were included in the analysis. Patients were divided into two groups: Group 1 included BPH patients with predominant voiding LUTS (68 Patients) while group 2 involved those with predominant storage LUTS (64 Patients). HoLEP was equally effective in management of both groups with significant improvement in urodynamics study (UDS) parameters, patient voiding and storage symptomatology, and IPSS from preoperatively to up to 6 months postoperatively with relatively low procedure complication rate and postoperative need for medication or procedure. Conclusions: HoLEP is a safe, effective, and reliable minimally invasive surgical modality that can be relied on for BPH patients with either predominant voiding or predominant storage symptoms with relatively low procedure complicat
Porreca A, D'Agostino D, Vigo M, et al. "In-bore" MRI prostate biopsy is a safe preoperative clinical tool to exclude significant prostate cancer in symptomatic patients with benign prostatic obstruction before transurethral laser enucleation. Arch Ital Urol Androl. 2020; 91:224-9. DOI: https://doi.org/10.4081/aiua.2019.4.224
Lee YJ, Oh SA, Kim SH, Oh SJ. Patient satisfaction after holmium laser enucleation of the prostate (HoLEP): A prospective cohort study. PLoS One. 2017; 12:e0182230. DOI: https://doi.org/10.1371/journal.pone.0182230
Gratzke C, Schlenker B, Seitz M, et al. Complications and early postoperative outcome after open prostatectomy in patients with benign prostatic enlargement: results of a prospective multicenter study. J Urol. 2007; 177:1419-22. DOI: https://doi.org/10.1016/j.juro.2006.11.062
Martin SA, Haren MT, Marshall VR, et al. Prevalence and factors associated with uncomplicated storage and voiding lower urinary tract symptoms in community-dwelling Australian men. World J Urol. 2011; 29:179-84. DOI: https://doi.org/10.1007/s00345-010-0605-8
Saito K, Hisasue S, Ide H, et al. The impact of increased bladder blood flow on storage symptoms after Holmium laser enucleation of the prostate. PLoS One. 2015; 10:e0129111. DOI: https://doi.org/10.1371/journal.pone.0129111
Peters TJ, Donovan JL, Kay HE, et al. The International Continence Society "Benign Prostatic Hyperplasia" Study: the botherosomeness of urinary symptoms. J Urol. 1997; 157:885-9. DOI: https://doi.org/10.1016/S0022-5347(01)65075-4
Gratzke C, Bachmann A, Descazeaud A, et al. EAU Guidelines on the assessment of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction. Eur Urol. 2015; 67:1099-109. DOI: https://doi.org/10.1016/j.eururo.2014.12.038
Rodrigues P, Meller A, Campagnari JC, et al. International Prostate Symptom Score--IPSS-AUA as discriminat scale in 400 male patients with lower urinary tract symptoms (LUTS). Int Braz J Urol. 2004; 30:135-41. DOI: https://doi.org/10.1590/S1677-55382004000200011
Barry MJ, Fowler FJ, Jr., O'Leary MP, et al. The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association. J Urol. 1992; 148:1549-57; discussion 64. DOI: https://doi.org/10.1016/S0022-5347(17)36966-5
O'Leary MP, Wei JT, Roehrborn CG, et al. Correlation of the International Prostate Symptom Score bother question with the Benign Prostatic Hyperplasia Impact Index in a clinical practice setting. BJU Int. 2008; 101:1531-5. DOI: https://doi.org/10.1111/j.1464-410X.2008.07574.x
Jeong J, Lee HS, Cho WJ, et al. Effect of detrusor overactivity on functional outcomes after Holmium laser enucleation of the prostate in patients with benign prostatic obstruction. Urology. 2015; 86:133-8. DOI: https://doi.org/10.1016/j.urology.2015.03.033
Schiavina R, Bianchi L, Giampaoli M, et al. Holmium laser prostatectomy in a tertiary Italian center: A prospective cost analysis in comparison with bipolar TURP and open prostatectomy. Arch Ital Urol Androl. 2020; 92:82-88. DOI: https://doi.org/10.4081/aiua.2020.2.82
Ryoo HS, Suh YS, Kim TH, et al. Efficacy of Holmium laser enucleation of the prostate based on patient preoperative characteristics. Int Neurourol J. 2015; 19:278-85. DOI: https://doi.org/10.5213/inj.2015.19.4.278
Romagnoli D, Ghaemian M, D'Agostino D, et al. Not fatal venous air embolism after holmium laser enucleation of the prostate: Case report and review of literature. Arch Ital Urol Androl. 2020; 92:55-7. DOI: https://doi.org/10.4081/aiua.2020.1.55
Wuerstle MC, Van Den Eeden SK, Poon KT, et al. Contribution of common medications to lower urinary tract symptoms in men. Arch Intern Med. 2011; 171:1680-2. DOI: https://doi.org/10.1001/archinternmed.2011.475
Abrams P, Cardozo L, Fall M, et al. The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Am J Obstet Gynecol. 2002; 187:116-26. DOI: https://doi.org/10.1067/mob.2002.125704
Allameh F, Basiri A, Razzaghi M, et al. Clinical efficacy of transurethral resection of the prostate combined with oral anticholinergics or botulinum toxin - A injection to treat benign prostatic hyperplasia with overactive bladder: a case-control study. Clin Pharmacol. 2020; 12:75-81. DOI: https://doi.org/10.2147/CPAA.S256051
Vavassori I, Valenti S, Naspro R, et al. Three-year outcome following holmium laser enucleation of the prostate combined with mechanical morcellation in 330 consecutive patients. Eur Urol. 2008; 53:599-604. DOI: https://doi.org/10.1016/j.eururo.2007.10.059
Pyun JH, Kang SG, Kang SH, et al. Efficacy of holmium laser enucleation of the prostate (HoLEP) in men with bladder outlet obstruction (BOO) and non-neurogenic bladder dysfunction. Kaohsiung J Med Sci. 2017; 33:458-63. DOI: https://doi.org/10.1016/j.kjms.2017.06.010
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
Downloads
Citations
